nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A4—Methylprednisolone—psoriatic arthritis	0.078	0.2	CbGbCtD
Vardenafil—CYP3A5—Dexamethasone—psoriatic arthritis	0.0757	0.194	CbGbCtD
Vardenafil—CYP3A4—Triamcinolone—psoriatic arthritis	0.0591	0.151	CbGbCtD
Vardenafil—CYP3A4—Betamethasone—psoriatic arthritis	0.0507	0.13	CbGbCtD
Vardenafil—CYP3A4—Prednisolone—psoriatic arthritis	0.0501	0.128	CbGbCtD
Vardenafil—CYP3A4—Prednisone—psoriatic arthritis	0.0473	0.121	CbGbCtD
Vardenafil—CYP3A4—Dexamethasone—psoriatic arthritis	0.0295	0.0756	CbGbCtD
Vardenafil—Vertigo—Triamcinolone—psoriatic arthritis	0.00125	0.00205	CcSEcCtD
Vardenafil—Syncope—Triamcinolone—psoriatic arthritis	0.00124	0.00204	CcSEcCtD
Vardenafil—Vertigo—Methylprednisolone—psoriatic arthritis	0.00124	0.00204	CcSEcCtD
Vardenafil—Syncope—Methylprednisolone—psoriatic arthritis	0.00124	0.00204	CcSEcCtD
Vardenafil—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00124	0.00203	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00123	0.00202	CcSEcCtD
Vardenafil—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00122	0.002	CcSEcCtD
Vardenafil—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00122	0.002	CcSEcCtD
Vardenafil—Shock—Prednisolone—psoriatic arthritis	0.00121	0.00199	CcSEcCtD
Vardenafil—Convulsion—Triamcinolone—psoriatic arthritis	0.0012	0.00197	CcSEcCtD
Vardenafil—Tachycardia—Prednisolone—psoriatic arthritis	0.0012	0.00197	CcSEcCtD
Vardenafil—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.0012	0.00197	CcSEcCtD
Vardenafil—Convulsion—Methylprednisolone—psoriatic arthritis	0.0012	0.00197	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00119	0.00195	CcSEcCtD
Vardenafil—Myalgia—Triamcinolone—psoriatic arthritis	0.00118	0.00194	CcSEcCtD
Vardenafil—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00118	0.00193	CcSEcCtD
Vardenafil—Myalgia—Methylprednisolone—psoriatic arthritis	0.00118	0.00193	CcSEcCtD
Vardenafil—Eye disorder—Prednisone—psoriatic arthritis	0.00118	0.00193	CcSEcCtD
Vardenafil—Anxiety—Methylprednisolone—psoriatic arthritis	0.00117	0.00193	CcSEcCtD
Vardenafil—Infestation NOS—Methotrexate—psoriatic arthritis	0.00117	0.00192	CcSEcCtD
Vardenafil—Infestation—Methotrexate—psoriatic arthritis	0.00117	0.00192	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00117	0.00192	CcSEcCtD
Vardenafil—Flushing—Prednisone—psoriatic arthritis	0.00117	0.00192	CcSEcCtD
Vardenafil—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00117	0.00192	CcSEcCtD
Vardenafil—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00117	0.00192	CcSEcCtD
Vardenafil—Discomfort—Triamcinolone—psoriatic arthritis	0.00117	0.00192	CcSEcCtD
Vardenafil—Discomfort—Methylprednisolone—psoriatic arthritis	0.00116	0.00191	CcSEcCtD
Vardenafil—Dry mouth—Triamcinolone—psoriatic arthritis	0.00116	0.0019	CcSEcCtD
Vardenafil—Angioedema—Dexamethasone—psoriatic arthritis	0.00115	0.00189	CcSEcCtD
Vardenafil—Angioedema—Betamethasone—psoriatic arthritis	0.00115	0.00189	CcSEcCtD
Vardenafil—Angiopathy—Prednisone—psoriatic arthritis	0.00114	0.00188	CcSEcCtD
Vardenafil—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00114	0.00187	CcSEcCtD
Vardenafil—Immune system disorder—Prednisone—psoriatic arthritis	0.00114	0.00187	CcSEcCtD
Vardenafil—Malaise—Dexamethasone—psoriatic arthritis	0.00114	0.00186	CcSEcCtD
Vardenafil—Malaise—Betamethasone—psoriatic arthritis	0.00114	0.00186	CcSEcCtD
Vardenafil—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00113	0.00186	CcSEcCtD
Vardenafil—Vertigo—Dexamethasone—psoriatic arthritis	0.00113	0.00186	CcSEcCtD
Vardenafil—Vertigo—Betamethasone—psoriatic arthritis	0.00113	0.00186	CcSEcCtD
Vardenafil—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00113	0.00185	CcSEcCtD
Vardenafil—Syncope—Betamethasone—psoriatic arthritis	0.00113	0.00185	CcSEcCtD
Vardenafil—Syncope—Dexamethasone—psoriatic arthritis	0.00113	0.00185	CcSEcCtD
Vardenafil—Infection—Triamcinolone—psoriatic arthritis	0.00113	0.00185	CcSEcCtD
Vardenafil—Sweating—Methotrexate—psoriatic arthritis	0.00112	0.00184	CcSEcCtD
Vardenafil—Infection—Methylprednisolone—psoriatic arthritis	0.00112	0.00184	CcSEcCtD
Vardenafil—Haematuria—Methotrexate—psoriatic arthritis	0.00112	0.00183	CcSEcCtD
Vardenafil—Shock—Triamcinolone—psoriatic arthritis	0.00111	0.00183	CcSEcCtD
Vardenafil—Insomnia—Prednisolone—psoriatic arthritis	0.00111	0.00183	CcSEcCtD
Vardenafil—Shock—Methylprednisolone—psoriatic arthritis	0.00111	0.00182	CcSEcCtD
Vardenafil—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00111	0.00182	CcSEcCtD
Vardenafil—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00111	0.00182	CcSEcCtD
Vardenafil—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00111	0.00182	CcSEcCtD
Vardenafil—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00111	0.00182	CcSEcCtD
Vardenafil—Epistaxis—Methotrexate—psoriatic arthritis	0.00111	0.00182	CcSEcCtD
Vardenafil—Paraesthesia—Prednisolone—psoriatic arthritis	0.00111	0.00181	CcSEcCtD
Vardenafil—Tachycardia—Triamcinolone—psoriatic arthritis	0.00111	0.00181	CcSEcCtD
Vardenafil—Mental disorder—Prednisone—psoriatic arthritis	0.0011	0.00181	CcSEcCtD
Vardenafil—Tachycardia—Methylprednisolone—psoriatic arthritis	0.0011	0.00181	CcSEcCtD
Vardenafil—Skin disorder—Methylprednisolone—psoriatic arthritis	0.0011	0.0018	CcSEcCtD
Vardenafil—Erythema—Prednisone—psoriatic arthritis	0.0011	0.0018	CcSEcCtD
Vardenafil—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.0011	0.0018	CcSEcCtD
Vardenafil—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00109	0.00179	CcSEcCtD
Vardenafil—Convulsion—Dexamethasone—psoriatic arthritis	0.00109	0.00179	CcSEcCtD
Vardenafil—Convulsion—Betamethasone—psoriatic arthritis	0.00109	0.00179	CcSEcCtD
Vardenafil—Myalgia—Dexamethasone—psoriatic arthritis	0.00107	0.00176	CcSEcCtD
Vardenafil—Myalgia—Betamethasone—psoriatic arthritis	0.00107	0.00176	CcSEcCtD
Vardenafil—Anxiety—Betamethasone—psoriatic arthritis	0.00107	0.00175	CcSEcCtD
Vardenafil—Anxiety—Dexamethasone—psoriatic arthritis	0.00107	0.00175	CcSEcCtD
Vardenafil—Discomfort—Dexamethasone—psoriatic arthritis	0.00106	0.00174	CcSEcCtD
Vardenafil—Discomfort—Betamethasone—psoriatic arthritis	0.00106	0.00174	CcSEcCtD
Vardenafil—Haemoglobin—Methotrexate—psoriatic arthritis	0.00106	0.00174	CcSEcCtD
Vardenafil—Hypotension—Methylprednisolone—psoriatic arthritis	0.00106	0.00173	CcSEcCtD
Vardenafil—Pain—Prednisolone—psoriatic arthritis	0.00105	0.00173	CcSEcCtD
Vardenafil—Haemorrhage—Methotrexate—psoriatic arthritis	0.00105	0.00173	CcSEcCtD
Vardenafil—Pharyngitis—Methotrexate—psoriatic arthritis	0.00105	0.00171	CcSEcCtD
Vardenafil—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00104	0.00171	CcSEcCtD
Vardenafil—Vision blurred—Prednisone—psoriatic arthritis	0.00103	0.0017	CcSEcCtD
Vardenafil—Urethral disorder—Methotrexate—psoriatic arthritis	0.00103	0.00169	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00103	0.00169	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00103	0.00169	CcSEcCtD
Vardenafil—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00103	0.00169	CcSEcCtD
Vardenafil—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00103	0.00169	CcSEcCtD
Vardenafil—Insomnia—Triamcinolone—psoriatic arthritis	0.00102	0.00168	CcSEcCtD
Vardenafil—Insomnia—Methylprednisolone—psoriatic arthritis	0.00102	0.00168	CcSEcCtD
Vardenafil—Infection—Dexamethasone—psoriatic arthritis	0.00102	0.00168	CcSEcCtD
Vardenafil—Infection—Betamethasone—psoriatic arthritis	0.00102	0.00168	CcSEcCtD
Vardenafil—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00102	0.00167	CcSEcCtD
Vardenafil—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00102	0.00167	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00102	0.00167	CcSEcCtD
Vardenafil—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00101	0.00167	CcSEcCtD
Vardenafil—Visual impairment—Methotrexate—psoriatic arthritis	0.00101	0.00166	CcSEcCtD
Vardenafil—Shock—Dexamethasone—psoriatic arthritis	0.00101	0.00166	CcSEcCtD
Vardenafil—Shock—Betamethasone—psoriatic arthritis	0.00101	0.00166	CcSEcCtD
Vardenafil—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00101	0.00166	CcSEcCtD
Vardenafil—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00101	0.00165	CcSEcCtD
Vardenafil—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00101	0.00165	CcSEcCtD
Vardenafil—Tachycardia—Betamethasone—psoriatic arthritis	0.001	0.00165	CcSEcCtD
Vardenafil—Tachycardia—Dexamethasone—psoriatic arthritis	0.001	0.00165	CcSEcCtD
Vardenafil—Angioedema—Prednisone—psoriatic arthritis	0.001	0.00164	CcSEcCtD
Vardenafil—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000997	0.00164	CcSEcCtD
Vardenafil—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000995	0.00163	CcSEcCtD
Vardenafil—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000994	0.00163	CcSEcCtD
Vardenafil—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000994	0.00163	CcSEcCtD
Vardenafil—Malaise—Prednisone—psoriatic arthritis	0.000989	0.00162	CcSEcCtD
Vardenafil—Vertigo—Prednisone—psoriatic arthritis	0.000985	0.00162	CcSEcCtD
Vardenafil—Eye disorder—Methotrexate—psoriatic arthritis	0.000984	0.00161	CcSEcCtD
Vardenafil—Syncope—Prednisone—psoriatic arthritis	0.000984	0.00161	CcSEcCtD
Vardenafil—Tinnitus—Methotrexate—psoriatic arthritis	0.000982	0.00161	CcSEcCtD
Vardenafil—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000977	0.0016	CcSEcCtD
Vardenafil—Pain—Triamcinolone—psoriatic arthritis	0.000969	0.00159	CcSEcCtD
Vardenafil—Loss of consciousness—Prednisone—psoriatic arthritis	0.000964	0.00158	CcSEcCtD
Vardenafil—Hypotension—Dexamethasone—psoriatic arthritis	0.00096	0.00158	CcSEcCtD
Vardenafil—Hypotension—Betamethasone—psoriatic arthritis	0.00096	0.00158	CcSEcCtD
Vardenafil—Angiopathy—Methotrexate—psoriatic arthritis	0.000955	0.00157	CcSEcCtD
Vardenafil—Immune system disorder—Methotrexate—psoriatic arthritis	0.000951	0.00156	CcSEcCtD
Vardenafil—Convulsion—Prednisone—psoriatic arthritis	0.00095	0.00156	CcSEcCtD
Vardenafil—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000949	0.00156	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000936	0.00154	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000936	0.00154	CcSEcCtD
Vardenafil—Myalgia—Prednisone—psoriatic arthritis	0.000934	0.00153	CcSEcCtD
Vardenafil—Arthralgia—Prednisone—psoriatic arthritis	0.000934	0.00153	CcSEcCtD
Vardenafil—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000933	0.00153	CcSEcCtD
Vardenafil—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000931	0.00153	CcSEcCtD
Vardenafil—Anxiety—Prednisone—psoriatic arthritis	0.00093	0.00153	CcSEcCtD
Vardenafil—Insomnia—Betamethasone—psoriatic arthritis	0.00093	0.00153	CcSEcCtD
Vardenafil—Insomnia—Dexamethasone—psoriatic arthritis	0.00093	0.00153	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000927	0.00152	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000924	0.00152	CcSEcCtD
Vardenafil—Paraesthesia—Betamethasone—psoriatic arthritis	0.000923	0.00151	CcSEcCtD
Vardenafil—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000923	0.00151	CcSEcCtD
Vardenafil—Discomfort—Prednisone—psoriatic arthritis	0.000923	0.00151	CcSEcCtD
Vardenafil—Mental disorder—Methotrexate—psoriatic arthritis	0.000922	0.00151	CcSEcCtD
Vardenafil—Erythema—Methotrexate—psoriatic arthritis	0.000917	0.0015	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000908	0.00149	CcSEcCtD
Vardenafil—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000905	0.00148	CcSEcCtD
Vardenafil—Dyspepsia—Betamethasone—psoriatic arthritis	0.000905	0.00148	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000895	0.00147	CcSEcCtD
Vardenafil—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000893	0.00147	CcSEcCtD
Vardenafil—Infection—Prednisone—psoriatic arthritis	0.000889	0.00146	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000887	0.00146	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000887	0.00146	CcSEcCtD
Vardenafil—Back pain—Methotrexate—psoriatic arthritis	0.000887	0.00145	CcSEcCtD
Vardenafil—Shock—Prednisone—psoriatic arthritis	0.000881	0.00144	CcSEcCtD
Vardenafil—Pain—Dexamethasone—psoriatic arthritis	0.000879	0.00144	CcSEcCtD
Vardenafil—Pain—Betamethasone—psoriatic arthritis	0.000879	0.00144	CcSEcCtD
Vardenafil—Nervous system disorder—Prednisone—psoriatic arthritis	0.000878	0.00144	CcSEcCtD
Vardenafil—Tachycardia—Prednisone—psoriatic arthritis	0.000874	0.00143	CcSEcCtD
Vardenafil—Skin disorder—Prednisone—psoriatic arthritis	0.000869	0.00143	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000865	0.00142	CcSEcCtD
Vardenafil—Vision blurred—Methotrexate—psoriatic arthritis	0.000864	0.00142	CcSEcCtD
Vardenafil—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00085	0.0014	CcSEcCtD
Vardenafil—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000847	0.00139	CcSEcCtD
Vardenafil—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000847	0.00139	CcSEcCtD
Vardenafil—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00084	0.00138	CcSEcCtD
Vardenafil—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00084	0.00138	CcSEcCtD
Vardenafil—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000835	0.00137	CcSEcCtD
Vardenafil—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000833	0.00137	CcSEcCtD
Vardenafil—Malaise—Methotrexate—psoriatic arthritis	0.000827	0.00136	CcSEcCtD
Vardenafil—Vertigo—Methotrexate—psoriatic arthritis	0.000824	0.00135	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000816	0.00134	CcSEcCtD
Vardenafil—Dizziness—Prednisolone—psoriatic arthritis	0.000815	0.00134	CcSEcCtD
Vardenafil—Asthenia—Triamcinolone—psoriatic arthritis	0.000813	0.00133	CcSEcCtD
Vardenafil—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000813	0.00133	CcSEcCtD
Vardenafil—Abdominal pain—Betamethasone—psoriatic arthritis	0.000813	0.00133	CcSEcCtD
Vardenafil—Asthenia—Methylprednisolone—psoriatic arthritis	0.000811	0.00133	CcSEcCtD
Vardenafil—Insomnia—Prednisone—psoriatic arthritis	0.00081	0.00133	CcSEcCtD
Vardenafil—Paraesthesia—Prednisone—psoriatic arthritis	0.000804	0.00132	CcSEcCtD
Vardenafil—Pruritus—Triamcinolone—psoriatic arthritis	0.000801	0.00131	CcSEcCtD
Vardenafil—Pruritus—Methylprednisolone—psoriatic arthritis	0.0008	0.00131	CcSEcCtD
Vardenafil—Convulsion—Methotrexate—psoriatic arthritis	0.000794	0.0013	CcSEcCtD
Vardenafil—Dyspepsia—Prednisone—psoriatic arthritis	0.000788	0.00129	CcSEcCtD
Vardenafil—Arthralgia—Methotrexate—psoriatic arthritis	0.00078	0.00128	CcSEcCtD
Vardenafil—Myalgia—Methotrexate—psoriatic arthritis	0.00078	0.00128	CcSEcCtD
Vardenafil—Chest pain—Methotrexate—psoriatic arthritis	0.00078	0.00128	CcSEcCtD
Vardenafil—Rash—Prednisolone—psoriatic arthritis	0.000777	0.00127	CcSEcCtD
Vardenafil—Dermatitis—Prednisolone—psoriatic arthritis	0.000776	0.00127	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000775	0.00127	CcSEcCtD
Vardenafil—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000773	0.00127	CcSEcCtD
Vardenafil—Headache—Prednisolone—psoriatic arthritis	0.000772	0.00127	CcSEcCtD
Vardenafil—Discomfort—Methotrexate—psoriatic arthritis	0.000771	0.00126	CcSEcCtD
Vardenafil—Dizziness—Triamcinolone—psoriatic arthritis	0.000749	0.00123	CcSEcCtD
Vardenafil—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000748	0.00123	CcSEcCtD
Vardenafil—Dizziness—Methylprednisolone—psoriatic arthritis	0.000747	0.00123	CcSEcCtD
Vardenafil—Infection—Methotrexate—psoriatic arthritis	0.000743	0.00122	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisone—psoriatic arthritis	0.000738	0.00121	CcSEcCtD
Vardenafil—Asthenia—Dexamethasone—psoriatic arthritis	0.000737	0.00121	CcSEcCtD
Vardenafil—Asthenia—Betamethasone—psoriatic arthritis	0.000737	0.00121	CcSEcCtD
Vardenafil—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000734	0.0012	CcSEcCtD
Vardenafil—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000732	0.0012	CcSEcCtD
Vardenafil—Nausea—Prednisolone—psoriatic arthritis	0.000732	0.0012	CcSEcCtD
Vardenafil—Pruritus—Betamethasone—psoriatic arthritis	0.000727	0.00119	CcSEcCtD
Vardenafil—Pruritus—Dexamethasone—psoriatic arthritis	0.000727	0.00119	CcSEcCtD
Vardenafil—Skin disorder—Methotrexate—psoriatic arthritis	0.000727	0.00119	CcSEcCtD
Vardenafil—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000723	0.00119	CcSEcCtD
Vardenafil—Vomiting—Triamcinolone—psoriatic arthritis	0.00072	0.00118	CcSEcCtD
Vardenafil—Vomiting—Methylprednisolone—psoriatic arthritis	0.000719	0.00118	CcSEcCtD
Vardenafil—Rash—Triamcinolone—psoriatic arthritis	0.000714	0.00117	CcSEcCtD
Vardenafil—Dermatitis—Triamcinolone—psoriatic arthritis	0.000714	0.00117	CcSEcCtD
Vardenafil—Rash—Methylprednisolone—psoriatic arthritis	0.000713	0.00117	CcSEcCtD
Vardenafil—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000712	0.00117	CcSEcCtD
Vardenafil—Headache—Triamcinolone—psoriatic arthritis	0.00071	0.00116	CcSEcCtD
Vardenafil—Headache—Methylprednisolone—psoriatic arthritis	0.000708	0.00116	CcSEcCtD
Vardenafil—Abdominal pain—Prednisone—psoriatic arthritis	0.000708	0.00116	CcSEcCtD
Vardenafil—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000703	0.00115	CcSEcCtD
Vardenafil—Diarrhoea—Betamethasone—psoriatic arthritis	0.000703	0.00115	CcSEcCtD
Vardenafil—Hypotension—Methotrexate—psoriatic arthritis	0.000699	0.00115	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000682	0.00112	CcSEcCtD
Vardenafil—Dizziness—Dexamethasone—psoriatic arthritis	0.00068	0.00112	CcSEcCtD
Vardenafil—Dizziness—Betamethasone—psoriatic arthritis	0.00068	0.00112	CcSEcCtD
Vardenafil—Insomnia—Methotrexate—psoriatic arthritis	0.000677	0.00111	CcSEcCtD
Vardenafil—Nausea—Triamcinolone—psoriatic arthritis	0.000673	0.0011	CcSEcCtD
Vardenafil—Paraesthesia—Methotrexate—psoriatic arthritis	0.000672	0.0011	CcSEcCtD
Vardenafil—Nausea—Methylprednisolone—psoriatic arthritis	0.000671	0.0011	CcSEcCtD
Vardenafil—Dyspnoea—Methotrexate—psoriatic arthritis	0.000667	0.00109	CcSEcCtD
Vardenafil—Somnolence—Methotrexate—psoriatic arthritis	0.000665	0.00109	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisone—psoriatic arthritis	0.000659	0.00108	CcSEcCtD
Vardenafil—Dyspepsia—Methotrexate—psoriatic arthritis	0.000658	0.00108	CcSEcCtD
Vardenafil—Vomiting—Betamethasone—psoriatic arthritis	0.000654	0.00107	CcSEcCtD
Vardenafil—Vomiting—Dexamethasone—psoriatic arthritis	0.000654	0.00107	CcSEcCtD
Vardenafil—Rash—Betamethasone—psoriatic arthritis	0.000648	0.00106	CcSEcCtD
Vardenafil—Rash—Dexamethasone—psoriatic arthritis	0.000648	0.00106	CcSEcCtD
Vardenafil—Dermatitis—Betamethasone—psoriatic arthritis	0.000647	0.00106	CcSEcCtD
Vardenafil—Dermatitis—Dexamethasone—psoriatic arthritis	0.000647	0.00106	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000646	0.00106	CcSEcCtD
Vardenafil—Headache—Betamethasone—psoriatic arthritis	0.000644	0.00106	CcSEcCtD
Vardenafil—Headache—Dexamethasone—psoriatic arthritis	0.000644	0.00106	CcSEcCtD
Vardenafil—Asthenia—Prednisone—psoriatic arthritis	0.000642	0.00105	CcSEcCtD
Vardenafil—Pain—Methotrexate—psoriatic arthritis	0.00064	0.00105	CcSEcCtD
Vardenafil—Pruritus—Prednisone—psoriatic arthritis	0.000633	0.00104	CcSEcCtD
Vardenafil—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000616	0.00101	CcSEcCtD
Vardenafil—Diarrhoea—Prednisone—psoriatic arthritis	0.000612	0.001	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000612	0.001	CcSEcCtD
Vardenafil—Nausea—Betamethasone—psoriatic arthritis	0.000611	0.001	CcSEcCtD
Vardenafil—Nausea—Dexamethasone—psoriatic arthritis	0.000611	0.001	CcSEcCtD
Vardenafil—Dizziness—Prednisone—psoriatic arthritis	0.000592	0.000971	CcSEcCtD
Vardenafil—Abdominal pain—Methotrexate—psoriatic arthritis	0.000591	0.00097	CcSEcCtD
Vardenafil—Vomiting—Prednisone—psoriatic arthritis	0.000569	0.000934	CcSEcCtD
Vardenafil—Rash—Prednisone—psoriatic arthritis	0.000564	0.000926	CcSEcCtD
Vardenafil—Dermatitis—Prednisone—psoriatic arthritis	0.000564	0.000925	CcSEcCtD
Vardenafil—Headache—Prednisone—psoriatic arthritis	0.000561	0.00092	CcSEcCtD
Vardenafil—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000551	0.000904	CcSEcCtD
Vardenafil—Asthenia—Methotrexate—psoriatic arthritis	0.000537	0.000881	CcSEcCtD
Vardenafil—Nausea—Prednisone—psoriatic arthritis	0.000532	0.000872	CcSEcCtD
Vardenafil—Pruritus—Methotrexate—psoriatic arthritis	0.000529	0.000868	CcSEcCtD
Vardenafil—Diarrhoea—Methotrexate—psoriatic arthritis	0.000512	0.00084	CcSEcCtD
Vardenafil—Dizziness—Methotrexate—psoriatic arthritis	0.000495	0.000812	CcSEcCtD
Vardenafil—Vomiting—Methotrexate—psoriatic arthritis	0.000476	0.00078	CcSEcCtD
Vardenafil—Rash—Methotrexate—psoriatic arthritis	0.000472	0.000774	CcSEcCtD
Vardenafil—Dermatitis—Methotrexate—psoriatic arthritis	0.000471	0.000773	CcSEcCtD
Vardenafil—Headache—Methotrexate—psoriatic arthritis	0.000469	0.000769	CcSEcCtD
Vardenafil—Nausea—Methotrexate—psoriatic arthritis	0.000444	0.000729	CcSEcCtD
